These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 29713798

  • 1. Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Thongprayoon C, Acharya P, Acharya C, Chenbhanich J, Bathini T, Boonpheng B, Sharma K, Wijarnpreecha K, Ungprasert P, Gonzalez Suarez ML, Cheungpasitporn W.
    Osteoporos Int; 2018 Aug; 29(8):1737-1745. PubMed ID: 29713798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of denosumab on bone mineral density and bone metabolism in patients with end-stage renal disease: A systematic review and meta-analysis.
    Gu Z, Yang X, Wang Y, Gao J.
    Hemodial Int; 2023 Oct; 27(4):352-363. PubMed ID: 37264758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Denosumab for dialysis patients with osteoporosis: A cohort study.
    Kunizawa K, Hiramatsu R, Hoshino J, Mizuno H, Ozawa Y, Sekine A, Kawada M, Sumida K, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Ubara Y, Takaichi K.
    Sci Rep; 2020 Feb 12; 10(1):2496. PubMed ID: 32051451
    [Abstract] [Full Text] [Related]

  • 9. Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients.
    Cianciolo G, Tondolo F, Barbuto S, Iacovella F, Zavatta G, Altieri P, Grandinetti V, Comai G, Cozzolino M, La Manna G.
    Am J Nephrol; 2021 Feb 12; 52(8):611-619. PubMed ID: 34518468
    [Abstract] [Full Text] [Related]

  • 10. Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
    Bird ST, Smith ER, Gelperin K, Jung TH, Thompson A, Kambhampati R, Lyu H, Zhao H, Zhao Y, Zhu Y, Easley O, Niak A, Wernecke M, Chillarige Y, Zemskova M, Kelman JA, Graham DJ.
    JAMA; 2024 Feb 13; 331(6):491-499. PubMed ID: 38241060
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of denosumab in osteoporotic hemodialysed patients.
    Festuccia F, Jafari MT, Moioli A, Fofi C, Barberi S, Amendola S, Sciacchitano S, Punzo G, Menè P.
    J Nephrol; 2017 Apr 13; 30(2):271-279. PubMed ID: 27394428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study.
    Tanaka S, Mizutani H, Tsuruya E, Fukuda R, Kuge K, Okubo N.
    J Bone Miner Metab; 2021 May 13; 39(3):463-473. PubMed ID: 33387064
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypocalcaemia after denosumab in older people following fracture.
    Chen J, Smerdely P.
    Osteoporos Int; 2017 Feb 13; 28(2):517-522. PubMed ID: 27682248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.
    Kinoshita Y, Arai M, Ito N, Takashi Y, Makita N, Nangaku M, Shinoda Y, Fukumoto S.
    Endocr J; 2016 May 31; 63(5):479-84. PubMed ID: 26860123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.